US Pharma’s financialised business model
“Price gouging in the US pharmaceutical drug industry goes back more than three decades. “In 1985 US Representative Henry Waxman, chair of the House Subcommittee on Health and the Environment, accused the pharmaceutical industry of “gouging the American public” with “outrageous” price increases, driven by “greed on a massive scale.” “Even in the wake of …
Continue reading ‘US Pharma’s financialised business model’ »